Kanurra Raises $6.35M Seed for Transparent Drug Pricing

August 3, 2026

Fundraise Insider tracks newly funded startups each week and delivers verified B2B leads list of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.

Kanurra, a New York City pharmacy benefit manager, has raised $6.35 million in a seed round. The financing was reported in late July 2026 and came from investors including Asylum Ventures, Daybreak Ventures, Virtue VC, Necessary Ventures, Ford Street Ventures and Browder Capital.

The company offers transparent, pass through drug pricing and administration aimed at small and midsize employers that fund their own health plans. Kanurra was founded in 2026 by Semih Gultekin.

With fresh capital in place, the company enters a crowded pharmacy benefits market pitching itself on price clarity for employers that have long struggled to see where their drug spending goes.

You may also like

35 Sales Email Tips to Crush Your Sales Game

In today’s digital age, email remains one of the most effective tools for reaching out to potential customers and driving sales. However, crafting a successful sales email can be tricky, as you need […]

Recently Funded Startups Are A Great Sales Target. Here’s Why.

The startup industry has been growing at an unprecedented rate in recent years, with billions of dollars being poured into the sector every year. This growth has created an opportunity for businesses to […]

How to Identify Your B2B Target Audience: A Comprehensive Guide

For any business to succeed, it is essential to target the right audience. In B2B marketing, identifying your target audience is even more important, as it helps you focus your efforts and resources […]